---
schema_version: "secwatch.filing_event.v1"
accession: "0001401914-23-000042"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2023-07-21T23:59:59+00:00"
generated_at: "2026-06-13T04:53:07.330090+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Daré Bioscience receives Nasdaq deficiency notice for bid price below $1.00; has until Jan 16, 2024 to regain compliance

## Summary
- Received Nasdaq letter on July 19, 2023, for failing Minimum Bid Price Requirement over 30 consecutive business days.
- Has 180 calendar days (until Jan 16, 2024) to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not, may be eligible for additional 180-day period if meeting other listing standards.
- Cannot assure compliance; considering options including reverse stock split.

## SEC filing metadata
- accession: 0001401914-23-000042
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2023-07-21T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000140191423000042/0001401914-23-000042-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000140191423000042/dare-20230719.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001401914-23-000042
- JSON: https://secwatch.observer/filing/0001401914-23-000042.json
- Plain text: https://secwatch.observer/filing/0001401914-23-000042.txt

## Key facts
- Listing & Compliance Notices
  Dare Bioscience, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: July 19, 2023, Daré Bioscience, Inc. (“Daré”) received a letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying Daré that, for the last 30 consecutive business days, the closing bid price for Daré’s common stock was below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Nasdaq letter has no immediate effect on the listing of Daré’s common stock on the Nasdaq Capital Market. In accordance with Nasdaq listing
  evidence_url: https://www.sec.gov/Archives/edgar/data/1401914/000140191423000042/0001401914-23-000042-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.